MultiplexDX 2023
Revolutionary Multiplex8+ diagnostics enables personalized cancer treatment
SK
CompaniesEquityFunded
Equity
Featured in
€7,500,000
Target amount
147
Investors
30%+ p.a.
Required return
You cannot invest in this opportunity at the moment